UNSPSC 51372122: Hydrocodone bitartrate

This classification denotes an opioid receptor agonist and antitussive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NO70W886KK. European Medicines Agency schedules Hydrocodone bitartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02559MIG. Hydrocodone bitartrate generally arises in the molecular formula 2C18H21NO3.2C4H6O6.5H2O. The term 'hydrocodone bitartrate' is a European Pharmacopoeia designation.

UNSPSC 51372122 Hydrocodone bitartrate, a Commodity code, does not reflect the actual procurement activity currently being pursued under this classification in state and local government. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems, not hydrocodone. The code's nominal scope (a controlled pharmaceutical product) and the work actually being bought are unrelated, indicating minimal or misclassified activity under this code in the state and local market.

Seminole County posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistency in the source record), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year term with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs, maintain workers' compensation and general liability insurance, and comply with E-Verify and drug-free workplace certification requirements. The procurement does not specify set-aside designations and may draw funding from FEMA, subjecting bidders to federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. No other state or local opportunities appear in the recent activity for this code.